These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2897857)

  • 1. Calmodulin antagonists of improved potency and specificity for use in the study of calmodulin biochemistry.
    MacNeil S; Griffin M; Cooke AM; Pettett NJ; Dawson RA; Owen R; Blackburn GM
    Biochem Pharmacol; 1988 May; 37(9):1717-23. PubMed ID: 2897857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of the anti-proliferative effects of calmodulin antagonists in cultured cells--W7 derivatives of improved cytostatic potential.
    Barton CH; Blackburn GM; Rees R; Bleehen SS; Senior JH; Munro DS; MacNeil S
    Carcinogenesis; 1987 Jul; 8(7):919-23. PubMed ID: 3594725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for the involvement of calmodulin in natural cytotoxicity using a range of calmodulin antagonists of varying potency and improved specificity.
    Rees RC; Parker S; Platts A; Blackburn MG; MacNeil S
    Biosci Rep; 1987 Oct; 7(10):771-5. PubMed ID: 2833953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Modulation of brain Ca2+-calmodulin-dependent phosphodiesterase activity by naphthalene sulfamides].
    Shaĭkhin SM; Muratova MV; Belov AA; Khropov IuV; Kulagin SV
    Biokhimiia; 1988 Aug; 53(8):1357-64. PubMed ID: 2847819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symmetric covalent linkage of N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7) results in novel derivatives with increased inhibitory activities against calcium/calmodulin complex.
    Yokokura H; Osawa M; Inoue T; Umezawa I; Naito Y; Ikura M; Hidaka H
    Drug Des Discov; 1999 Nov; 16(3):203-16. PubMed ID: 10624566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calmodulin and protein kinase C antagonists also inhibit the Ca2+-dependent protein protease, calpain I.
    Brumley LM; Wallace RW
    Biochem Biophys Res Commun; 1989 Mar; 159(3):1297-303. PubMed ID: 2539150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for transglutaminase in glucose-stimulated insulin release from the pancreatic beta-cell.
    Bungay PJ; Owen RA; Coutts IC; Griffin M
    Biochem J; 1986 Apr; 235(1):269-78. PubMed ID: 2874792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibitor of calmodulin and calmodulin dependent enzyme].
    Hidaka H; Naito Y
    Tanpakushitsu Kakusan Koso; 1998 Sep; 43(12 Suppl):1732-8. PubMed ID: 9788175
    [No Abstract]   [Full Text] [Related]  

  • 9. Hydrophobic interaction of the Ca2+-calmodulin complex with calmodulin antagonists. Naphthalenesulfonamide derivatives.
    Tanaka T; Ohmura T; Hidaka H
    Mol Pharmacol; 1982 Sep; 22(2):403-7. PubMed ID: 7144734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the adhesion of Chinese hamster ovary cells by the naphthylsulfonamides dansylcadaverine and N-(6-aminohexyl)-5-chloro-1-naphthylenesulfonamide (W7).
    Cornwell MM; Juliano RL; Davies PJ
    Biochim Biophys Acta; 1983 Jun; 762(3):414-9. PubMed ID: 6133561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of extracellular-regulated kinase by 5-hydroxytryptamine(2A) receptors in PC12 cells is protein kinase C-independent and requires calmodulin and tyrosine kinases.
    Quinn JC; Johnson-Farley NN; Yoon J; Cowen DS
    J Pharmacol Exp Ther; 2002 Nov; 303(2):746-52. PubMed ID: 12388661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two types of calcium-dependent protein phosphorylations modulated by calmodulin antagonists. Naphthalenesulfonamide derivatives.
    Tanaka T; Ohmura T; Yamakado T; Hidaka H
    Mol Pharmacol; 1982 Sep; 22(2):408-12. PubMed ID: 6897280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of myeloid differentiation of HL-60 cells with naphthalene sulfonamide calmodulin antagonists.
    Veigl ML; Sedwick WD; Niedel J; Branch ME
    Cancer Res; 1986 May; 46(5):2300-5. PubMed ID: 3008985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calmodulin antagonists enhance calcium binding to calmodulin.
    Inagaki M; Tanaka T; Hidaka H
    Pharmacology; 1983; 27(3):125-9. PubMed ID: 6622516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity-structure relationship of calmodulin antagonists, Naphthalenesulfonamide derivatives.
    Hidaka H; Asano M; Tanaka T
    Mol Pharmacol; 1981 Nov; 20(3):571-8. PubMed ID: 7329399
    [No Abstract]   [Full Text] [Related]  

  • 16. Calmodulin antagonism and growth-inhibiting activity of triphenylethylene antiestrogens in MCF-7 human breast cancer cells.
    Gulino A; Barrera G; Vacca A; Farina A; Ferretti C; Screpanti I; Dianzani MU; Frati L
    Cancer Res; 1986 Dec; 46(12 Pt 1):6274-8. PubMed ID: 3022916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of calmodulin-like activity in term human amnion: effect of calmodulin inhibitors on prostaglandin biosynthesis.
    Olson DM; Kramar D; Smieja Z
    J Dev Physiol; 1987 Jun; 9(3):271-85. PubMed ID: 3038990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naphthalenesulfonamides as calmodulin antagonists and protein kinase inhibitors.
    Inagaki M; Kawamoto S; Itoh H; Saitoh M; Hagiwara M; Takahashi J; Hidaka H
    Mol Pharmacol; 1986 Jun; 29(6):577-81. PubMed ID: 2872589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct interaction of calmodulin antagonists with Ca2+/calmodulin-dependent cyclic nucleotide phosphodiesterase.
    Itoh H; Hidaka H
    J Biochem; 1984 Dec; 96(6):1721-6. PubMed ID: 6099352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calmodulin antagonists increase the amount of mRNA for the low-density-lipoprotein receptor in skin fibroblasts.
    Eckardt H; Filipovic I; Hasilik A; Buddecke E
    Biochem J; 1988 Jun; 252(3):889-92. PubMed ID: 3421929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.